지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
This study was conducted to identify the overall PPI usage from 2002 to 2013 (12 years) in real world settings using the sample cohort data from the National Health Insurance Service. The number of PPI users increased by about 10.6 times over 12 years and the average annual growth rate was 26.5%. Annual PPI drug expenditure increased by 16.8 times during the period, with an average annual growth rate of 31.6%. PPI products mainly were prescribed in clinics, as primary medical institutions, accounting for 65% of overall prescriptions. Rabeprazole was the most frequently prescribed ingredient among the seven PPIs available in Korea, accounting for about 51% of all PPI users. Although rabeprazole accounted for more than half of the prescriptions in clinic (rabeprazole 55.5%, esomeprazole 21.0%), it was used at similar levels to esomeprazole in general hospitals (rabeprazole 31.1%, esomeprazole 29.8%). Taking into account rapid increase of PPI usage over 12 years, it is necessary to further discussion to establish strategy for safe use of PPI.
목차
등록된 정보가 없습니다.
참고문헌 (19)
참고문헌 신청
Malfertheiner, P. / 2017 / Proton-pump inhibitors: understanding the complications and risks / Nat Rev Gastroenterol Hepatol 14:697
Lee, J. / 2013 / A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate / J Gastroenterol 48:1016
Abraham, N. S. / 2010 / ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on eeducing the gastrointestinal risks of antiplatelet therapy and NSAID use: American College of Cardiology Foundation Task Force on Expert Consensus Documents / J Am Coll Cardiol 56:2051
Vakil, N. / 2012 / Prescribing proton pump inhibitors: is it time to pause and rethink? / Drugs 72:437
Lanas, A. / 2016 / We are using too many PPIs, and we need to stop: A European perspective / Am J Gastroenterol 111:1085
Lee, J. / 2013 / A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate / J Gastroenterol 48:1016
Abraham, N. S. / 2010 / ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on eeducing the gastrointestinal risks of antiplatelet therapy and NSAID use: American College of Cardiology Foundation Task Force on Expert Consensus Documents / J Am Coll Cardiol 56:2051
Vakil, N. / 2012 / Prescribing proton pump inhibitors: is it time to pause and rethink? / Drugs 72:437
Lanas, A. / 2016 / We are using too many PPIs, and we need to stop: A European perspective / Am J Gastroenterol 111:1085
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
국민건강보험 12년 표본코호트자료를 이용한 프로톤펌프억제제 사용과 골절 위험의 연관성
한국임상약학회지
2019 .01
-
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Gut and Liver
2017 .01
-
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Journal of Neurogastroenterology and Motility (JNM)
2018 .01
-
Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients
Gut and Liver
2016 .01
-
신장이식 환자에게 위장관계 증상 예방 목적으로 투여하는 Proton Pump Inhibitors (PPIs) 안전성 비교분석
병원약사회지
2020 .01
-
In Vitro Effects of Rabeprazole on Human Pylorus Tone
Journal of Neurogastroenterology and Motility (JNM)
2015 .01
-
Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
Kidney Research and Clinical Practice
2015 .01
-
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy
Gut and Liver
2016 .01
-
Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
대한골대사학회지
2018 .01
-
Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
Kidney Research and Clinical Practice
2018 .01
-
Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
Journal of Neurogastroenterology and Motility (JNM)
2021 .10
-
A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
Journal of Neurogastroenterology and Motility (JNM)
2021 .01
-
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease
Gut and Liver
2018 .01
-
Association between long-term exposure to air pollution and mortality using National Health Insurance Service-National Sample Cohort (NHIS-NSC) : data issues and suggestions
환경독성보건학회 심포지엄 및 학술대회
2015 .10
-
Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
Journal of Neurogastroenterology and Motility (JNM)
2018 .01
-
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study
Journal of Korean Medical Science
2023 .04
-
중환자에서 스트레스성 궤양 예방 약물에 따른 감염성 합병증 발생률 비교
한국임상약학회지
2016 .01
-
Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
Gut and Liver
2016 .01
-
국민건강보험공단 청구자료를 활용한 파킨슨병과 관련된 코호트 연구 디자인 분석 및 향후 한의중재 관련 파킨슨 후향적 코호트 연구를 위한 제언
대한예방한의학회지
2024 .04
-
Introducing big data analysis using data from National Health Insurance Service
Korean Journal of Anesthesiology
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0